Greene Barry E 4
4 · Sage Therapeutics, Inc. · Filed Feb 15, 2024
Insider Transaction Report
Form 4
Greene Barry E
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2024-02-13+168,000→ 168,000 totalExercise: $23.02Exp: 2034-02-13→ Common Stock (168,000 underlying)
Footnotes (1)
- [F1]The securities awarded on February 13, 2024 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. Options to purchase 42,000 shares of common stock shall vest on the one year anniversary of February 13, 2024, with 126,000 shares vesting in 36 equal monthly installments thereafter.